Long-Term Safety of Endoscopic Biliary Stents for Cholangitis Complicating Choledocholithiasis: A Multi-Center Study.
biliary
cholangitis
long-term
safety
stents
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Sep 2020
12 Sep 2020
Historique:
received:
04
08
2020
revised:
27
08
2020
accepted:
10
09
2020
entrez:
16
9
2020
pubmed:
17
9
2020
medline:
17
9
2020
Statut:
epublish
Résumé
Treatment of cholangitis complicating choledocholithiasis includes biliary sphincterotomy and stone extraction. In certain cases of elderly comorbid patients with high risk for definitive endoscopic treatment, biliary stenting is the only measure for relieving biliary obstruction. We aimed to report the safety of retained biliary stone. a multi-center, retrospective case-control study conducted at two Israeli medical centers from January 2013 to December 2018 including all patients 18 years of age or older who underwent ERCP and biliary stent insertion for the treatment of acute cholangitis due to choledocholithiasis. Three-hundred and eight patients were identified. Eighty-three patients had retained long-term biliary stents of more than 6 months (group A) from insertion compared to 225 patients whose biliary stents were removed within a 6-month period (group B). The mean follow-up in group A was 66.1± 16.3 vs. 11.1 ± 2.7 weeks in group B. Overall complications during the follow-up were similar between groups A and B (6% vs. 4.9%, OR 1.24, Chi square 0.69). Similarly, the rate of each complication alone was not different when comparing group A to group B (3.6%, 1.2% and 1.2% vs. 2.7%, 0.44% and 1.8%) for cholangitis, stent related pancreatitis and biliary colic, respectively (Chi square 0.85). Even after 12 months, the rates of overall complications and each complication alone were not higher compared to less than 12 months (Chi square 0.72 and 0.8, respectively). endoscopic biliary stenting for cholangitis complicating choledocholithiasis is safe for the long-term period without increase in stent related complications.
Sections du résumé
BACKGROUND
BACKGROUND
Treatment of cholangitis complicating choledocholithiasis includes biliary sphincterotomy and stone extraction. In certain cases of elderly comorbid patients with high risk for definitive endoscopic treatment, biliary stenting is the only measure for relieving biliary obstruction.
AIM
OBJECTIVE
We aimed to report the safety of retained biliary stone.
METHODS
METHODS
a multi-center, retrospective case-control study conducted at two Israeli medical centers from January 2013 to December 2018 including all patients 18 years of age or older who underwent ERCP and biliary stent insertion for the treatment of acute cholangitis due to choledocholithiasis.
RESULTS
RESULTS
Three-hundred and eight patients were identified. Eighty-three patients had retained long-term biliary stents of more than 6 months (group A) from insertion compared to 225 patients whose biliary stents were removed within a 6-month period (group B). The mean follow-up in group A was 66.1± 16.3 vs. 11.1 ± 2.7 weeks in group B. Overall complications during the follow-up were similar between groups A and B (6% vs. 4.9%, OR 1.24, Chi square 0.69). Similarly, the rate of each complication alone was not different when comparing group A to group B (3.6%, 1.2% and 1.2% vs. 2.7%, 0.44% and 1.8%) for cholangitis, stent related pancreatitis and biliary colic, respectively (Chi square 0.85). Even after 12 months, the rates of overall complications and each complication alone were not higher compared to less than 12 months (Chi square 0.72 and 0.8, respectively).
CONCLUSION
CONCLUSIONS
endoscopic biliary stenting for cholangitis complicating choledocholithiasis is safe for the long-term period without increase in stent related complications.
Identifiants
pubmed: 32932631
pii: jcm9092953
doi: 10.3390/jcm9092953
pmc: PMC7564722
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 1996 Sep 21;348(9030):791-3
pubmed: 8813987
J Gastroenterol. 2006 Aug;41(8):765-71
pubmed: 16988765
World J Gastrointest Endosc. 2015 Aug 25;7(11):1023-31
pubmed: 26322155
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Dig Endosc. 2017 Apr;29 Suppl 2:70-77
pubmed: 28425650
Clin Endosc. 2016 Mar;49(2):124-30
pubmed: 26911896
World J Gastrointest Endosc. 2018 Jan 16;10(1):45-50
pubmed: 29375741
Lancet. 1989 Aug 19;2(8660):431-4
pubmed: 2569609
Dig Dis Sci. 2012 Sep;57(9):2446-50
pubmed: 22573343
Ann R Coll Surg Engl. 2010 May;92(4):W27-31
pubmed: 20501006
Endosc Int Open. 2017 Apr;5(4):E261-E271
pubmed: 28382324
World J Gastroenterol. 2017 Jan 28;23(4):622-628
pubmed: 28216968
Gastrointest Endosc. 1992 May-Jun;38(3):341-6
pubmed: 1607087
World J Gastroenterol. 2007 Dec 21;13(47):6314-20
pubmed: 18081218
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Gastroenterology. 2020 Jul;159(1):363-366.e3
pubmed: 32283102
Semin Liver Dis. 1990 Aug;10(3):205-21
pubmed: 1977201
Hepatogastroenterology. 2001 Jan-Feb;48(37):56-8
pubmed: 11268999
Endoscopy. 1998 May;30(4):356-9
pubmed: 9689508
Endoscopy. 2013 Dec;45(12):1014-7
pubmed: 24288221
Gastrointest Endosc. 1995 Sep;42(3):195-201
pubmed: 7498682
Dig Endosc. 2013 Jul;25(4):440-3
pubmed: 23808949
Br J Surg. 1991 Apr;78(4):473-6
pubmed: 2032109
Endoscopy. 2001 Sep;33(9):786-90
pubmed: 11558033
Gastrointest Endosc. 1987 Dec;33(6):411-2
pubmed: 3443257